Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide

Semaglutide is a representative of analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently used in Russia for the treatment of type 2 diabetes mellitus (T2DM; in monotherapy and in combination therapy), including patients with obesity and overweight.The aim of the wo...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, V. S. Scherbakova, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, E. Yu. Kesova, E. D. Kozlov, E. S. Samoshkina, D. N. Andreev, Yu. G. Kazaishvili, S. M. Noskov, L. A. Balykova
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2024-01-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	glucagon-like peptide-1 glp-1 bioequivalence pharmacokinetics semaglutide type 2 diabetes mellitus physicochemical properties safety profile biological activity
Online Access:	https://www.pharmpharm.ru/jour/article/view/1385
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide

Similar Items